VINC
Vincerx Pharma Inc

2,068
Loading...
Loading...
Vincerx Pharma, Inc. operates as a clinical-stage biopharmaceutical company which develops antibody drugs. It focuses on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs for the treatment of cancer. The firm pipeline is derived from a license agreement with Bayer and includes: a clinical-stage and follow-on small molecule drug program and preclinical stage bioconjugation/next-generation antibody-drug conjugate platform. The company was founded by Ahmed M. Hamdy, Raquel E. Izumi, Tom C. Thomas, Soo In Hwang and John C. Byrd on December 19, 2018 and is headquartered in Palo Alto, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
13

Frequently Asked Questions

What is Market Cap of Vincerx Pharma Inc?
What is the 52-week high for Vincerx Pharma Inc?
What is the 52-week low for Vincerx Pharma Inc?
What is Vincerx Pharma Inc stock price today?
What was Vincerx Pharma Inc stock price yesterday?
What is the PE ratio of Vincerx Pharma Inc?
What is the Price-to-Book ratio of Vincerx Pharma Inc?
What is the 50-day moving average of Vincerx Pharma Inc?
How many employess does Vincerx Pharma Inc has?

Latest VINC News

View

Advertisement. Remove ads.

Advertisement. Remove ads.